Member Info for Marty130

Will we hit 10p soon today, if not then tomorrow definitely.. We are in a upwards trend..

One thing for sure, lowering the price has brought the buyers back..

Manipulation!! Surely we'll see a bounce after the Dow opens.

Was badly handled! Perhaps the Americans may see it in better light, when they open.

Agreed

I didn't say that, I was reflecting on what happened during the a previous takeover bid in 2023.

Agreed

May get an offer as has previously taken place.. SP peaked at 40p..

Biotechs usually do..

Games are possibly being played, yes it worked, the share price reduced, enabling big funds to buy in at lower prices, possibly with confidence for the future.

I am way down too, but find holding out works for me.. RENX have still to receive the CE mark and presumably the EU deals will follow..

Now passed 8p, potentially closing at 10.

The RNS was a nothing 🍔 burger..

Renalytix plc reported unaudited revenues of $1.6 million for the first half of fiscal year 2026, with full-year revenue guidance now projected at approximately $4 million, representing a 33% year-over-year increase

Where's the rns?

Smashing passed 8p.

Been involved with hvivo for some time now. They are about to announce a huge, multi million contract. Could be massive..

Any thoughts on opening prices in the morning, for me I would say 8/9p.

Proceeds from the Series B financing will support the advancement of ILiAD’s next generation pertussis vaccine candidate, BPZE1. Inducing both systemic and mucosal immunity, BPZE1 is a live attenuated intranasal pertussis vaccine designed to provide durable and comprehensive immunity for the prevention of B. pertussis infection, disease (whooping cough), and transmission. The Company expects to begin a pivotal human challenge trial of BPZE1 in 2026, with initial data expected in 2027.

Looking forward to hearing from Mo in the morning..